269 related articles for article (PubMed ID: 30544833)
21. VDAC1 at the crossroads of cell metabolism, apoptosis and cell stress.
Shoshan-Barmatz V; Maldonado EN; Krelin Y
Cell Stress; 2017 Oct; 1(1):11-36. PubMed ID: 30542671
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of VDAC1 prevents Ca²⁺-mediated oxidative stress and apoptosis induced by 5-aminolevulinic acid mediated sonodynamic therapy in THP-1 macrophages.
Chen H; Gao W; Yang Y; Guo S; Wang H; Wang W; Zhang S; Zhou Q; Xu H; Yao J; Tian Z; Li B; Cao W; Zhang Z; Tian Y
Apoptosis; 2014 Dec; 19(12):1712-26. PubMed ID: 25342393
[TBL] [Abstract][Full Text] [Related]
23. CoQ
Hseu YC; Thiyagarajan V; Ou TT; Yang HL
Arch Toxicol; 2018 Jan; 92(1):301-322. PubMed ID: 28918503
[TBL] [Abstract][Full Text] [Related]
24. VDAC1-interacting anion transport inhibitors inhibit VDAC1 oligomerization and apoptosis.
Ben-Hail D; Shoshan-Barmatz V
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1612-23. PubMed ID: 27064145
[TBL] [Abstract][Full Text] [Related]
25. VDAC1: from structure to cancer therapy.
Shoshan-Barmatz V; Mizrachi D
Front Oncol; 2012; 2():164. PubMed ID: 23233904
[TBL] [Abstract][Full Text] [Related]
26. The Mitochondrial Voltage-Dependent Anion Channel 1, Ca
Shoshan-Barmatz V; De S; Meir A
Front Oncol; 2017; 7():60. PubMed ID: 28443244
[TBL] [Abstract][Full Text] [Related]
27. Clinical implication of voltage-dependent anion channel 1 in uterine cervical cancer and its action on cervical cancer cells.
Wu CH; Lin YW; Wu TF; Ko JL; Wang PH
Oncotarget; 2016 Jan; 7(4):4210-25. PubMed ID: 26716410
[TBL] [Abstract][Full Text] [Related]
28. Dysfunction in the mitochondrial Fe-S assembly machinery leads to formation of the chemoresistant truncated VDAC1 isoform without HIF-1α activation.
Ferecatu I; Canal F; Fabbri L; Mazure NM; Bouton C; Golinelli-Cohen MP
PLoS One; 2018; 13(3):e0194782. PubMed ID: 29596470
[TBL] [Abstract][Full Text] [Related]
29. VDAC1 functions in Ca
Shoshan-Barmatz V; Krelin Y; Shteinfer-Kuzmine A
Cell Calcium; 2018 Jan; 69():81-100. PubMed ID: 28712506
[TBL] [Abstract][Full Text] [Related]
30. Mitochondrial fission factor is a novel Myc-dependent regulator of mitochondrial permeability in cancer.
Seo JH; Agarwal E; Chae YC; Lee YG; Garlick DS; Storaci AM; Ferrero S; Gaudioso G; Gianelli U; Vaira V; Altieri DC
EBioMedicine; 2019 Oct; 48():353-363. PubMed ID: 31542392
[TBL] [Abstract][Full Text] [Related]
31. Antifungal drug itraconazole targets VDAC1 to modulate the AMPK/mTOR signaling axis in endothelial cells.
Head SA; Shi W; Zhao L; Gorshkov K; Pasunooti K; Chen Y; Deng Z; Li RJ; Shim JS; Tan W; Hartung T; Zhang J; Zhao Y; Colombini M; Liu JO
Proc Natl Acad Sci U S A; 2015 Dec; 112(52):E7276-85. PubMed ID: 26655341
[TBL] [Abstract][Full Text] [Related]
32. Oligomerization of the mitochondrial protein VDAC1: from structure to function and cancer therapy.
Shoshan-Barmatz V; Mizrachi D; Keinan N
Prog Mol Biol Transl Sci; 2013; 117():303-34. PubMed ID: 23663973
[TBL] [Abstract][Full Text] [Related]
33. VDAC1 as a Player in Mitochondria-Mediated Apoptosis and Target for Modulating Apoptosis.
Shoshan-Barmatz V; Krelin Y; Chen Q
Curr Med Chem; 2017; 24(40):4435-4446. PubMed ID: 28618997
[TBL] [Abstract][Full Text] [Related]
34. Expression of a truncated active form of VDAC1 in lung cancer associates with hypoxic cell survival and correlates with progression to chemotherapy resistance.
Brahimi-Horn MC; Ben-Hail D; Ilie M; Gounon P; Rouleau M; Hofman V; Doyen J; Mari B; Shoshan-Barmatz V; Hofman P; Pouysségur J; Mazure NM
Cancer Res; 2012 Apr; 72(8):2140-50. PubMed ID: 22389449
[TBL] [Abstract][Full Text] [Related]
35. Vorinostat synergizes with EGFR inhibitors in NSCLC cells by increasing ROS via up-regulation of the major mitochondrial porin VDAC1 and modulation of the c-Myc-NRF2-KEAP1 pathway.
Leone A; Roca MS; Ciardiello C; Terranova-Barberio M; Vitagliano C; Ciliberto G; Mancini R; Di Gennaro E; Bruzzese F; Budillon A
Free Radic Biol Med; 2015 Dec; 89():287-99. PubMed ID: 26409771
[TBL] [Abstract][Full Text] [Related]
36. Key regions of VDAC1 functioning in apoptosis induction and regulation by hexokinase.
Shoshan-Barmatz V; Zakar M; Rosenthal K; Abu-Hamad S
Biochim Biophys Acta; 2009 May; 1787(5):421-30. PubMed ID: 19094960
[TBL] [Abstract][Full Text] [Related]
37. The role of calcium in VDAC1 oligomerization and mitochondria-mediated apoptosis.
Keinan N; Pahima H; Ben-Hail D; Shoshan-Barmatz V
Biochim Biophys Acta; 2013 Jul; 1833(7):1745-54. PubMed ID: 23542128
[TBL] [Abstract][Full Text] [Related]
38. Apoptosis is regulated by the VDAC1 N-terminal region and by VDAC oligomerization: release of cytochrome c, AIF and Smac/Diablo.
Shoshan-Barmatz V; Keinan N; Abu-Hamad S; Tyomkin D; Aram L
Biochim Biophys Acta; 2010; 1797(6-7):1281-91. PubMed ID: 20214874
[TBL] [Abstract][Full Text] [Related]
39. Increase in primary cilia number and length upon VDAC1 depletion contributes to attenuated proliferation of cancer cells.
Dutta A; Halder P; Gayen A; Mukherjee A; Mukherjee C; Majumder S
Exp Cell Res; 2023 Aug; 429(2):113671. PubMed ID: 37276998
[TBL] [Abstract][Full Text] [Related]
40. Hexokinase 2 Is a Pivot for Lovastatin-induced Glycolysis-to-Autophagy Reprogramming in Triple-Negative Breast Cancer Cells.
Xue L; Wu M; Li Y; Chen S; Wu M; Zhu J; Ding S; Zhang Q; Zheng C; He G; Fu S; Li G; Deng X
J Cancer; 2022; 13(12):3368-3377. PubMed ID: 36186902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
